product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Human CD28 Antibody
catalog :
MAB342-100
quantity :
100 ug (also 25 ug, 500 ug)
price :
489 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
37407
reactivity :
human, mouse
application :
western blot, immunocytochemistry, neutralization, flow cytometry
more info or order :
citations: 48
Reference
Popugailo A, Rotfogel Z, Levy M, Turgeman O, Hillman D, Levy R, et al. The homodimer interfaces of costimulatory receptors B7 and CD28 control their engagement and pro-inflammatory signaling. J Biomed Sci. 2023;30:49 pubmed publisher
Mez x151 si Csapl xe1 r M, Sz xf6 x151 r x, Vereb G. CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells. Cancers (Basel). 2023;15: pubmed publisher
Liu S, Zhang Q, Zhang M, Zhong X, Wang W, Wang L, et al. Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis. Biomol Biomed. 2023;23:248-258 pubmed publisher
Bretheau F, Castellanos Molina A, B xe9 langer D, Kusik M, Mailhot B, Boisvert A, et al. The alarmin interleukin-1α triggers secondary degeneration through reactive astrocytes and endothelium after spinal cord injury. Nat Commun. 2022;13:5786 pubmed publisher
Lanna A, Vaz B, D Ambra C, Valvo S, Vuotto C, Chiurchi xf9 V, et al. An intercellular transfer of telomeres rescues T cells from senescence and promotes long-term immunological memory. Nat Cell Biol. 2022;24:1461-1474 pubmed publisher
Yang L, Liu S, Zhang Q, Jia S, Qiu C, Jin Z. Overexpression of ascitic interleukin-35 induces CD8+ T cell exhaustion in liver cirrhotic patients with spontaneous bacterial peritonitis. Int Immunopharmacol. 2022;108:108729 pubmed publisher
Guo J, Luo N, Ai G, Yang W, Zhu J, Li C, et al. Eradicating tumor in a recurrent cervical cancer patient with autologous tumor-infiltrating lymphocytes and a modified lymphodepleting regimen. J Immunother Cancer. 2022;10: pubmed publisher
Jeong M, Zhou K, Park S, An H, Kwon Y, Chang Y, et al. Analysis of transient membrane protein interactions by single-molecule diffusional mobility shift assay. Exp Mol Med. 2021;53:291-299 pubmed publisher
Zhuang X, Maione F, Robinson J, Bentley M, Kaul B, Whitworth K, et al. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth. JCI Insight. 2020;5: pubmed publisher
Huetter J, Gritzan U, Gutcher I, Doecke W, Luetke Eversloh M, Golfier S, et al. Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2). Cancer Immunol Res. 2020;8:895-911 pubmed publisher
Hu Z, Yu P, Du G, Wang W, Zhu H, Li N, et al. PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice. PLoS ONE. 2020;15:e0228339 pubmed publisher
Tiirikainen M, Woetmann A, Norsgaard H, Santamaria Babi L, Lovato P. Ex vivo culture of lesional psoriasis skin for pharmacological testing. J Dermatol Sci. 2020;97:109-116 pubmed publisher
Lu Y, Yoo B, Ng A, Kim J, Yeom S, TANG J, et al. 4D electron microscopy of T cell activation. Proc Natl Acad Sci U S A. 2019;116:22014-22019 pubmed publisher
Chamcheu J, Esnault S, Adhami V, Noll A, Banang Mbeumi S, Roy T, et al. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells. 2019;8: pubmed publisher
Zhou N, Wang K, Fu Z. Effect of morphine and a low dose of ketamine on the T cells of patients with refractory cancer pain in vitro. Oncol Lett. 2019;18:4230-4236 pubmed publisher
Garrett S, Zhao Q, Feghali Bostwick C. Induction of a Th17 Phenotype in Human Skin-A Mimic of Dermal Inflammatory Diseases. Methods Protoc. 2019;2: pubmed publisher
Bensch F, van der Veen E, Lub de Hooge M, Jorritsma Smit A, Boellaard R, Kok I, et al. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nat Med. 2018;24:1852-1858 pubmed publisher
Giacomet V, Masetti M, Nannini P, Forlanini F, Clerici M, Zuccotti G, et al. Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults. PLoS ONE. 2018;13:e0192638 pubmed publisher
Caer C, Rouault C, Le Roy T, Poitou C, Aron Wisnewsky J, Torcivia A, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep. 2017;7:3000 pubmed publisher
Nakachi S, Sumitomo S, Tsuchida Y, Tsuchiya H, Kono M, Kato R, et al. Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Res Ther. 2017;19:97 pubmed publisher
Tao C, Shao H, Zhang W, Bo H, Wu F, Shen H, et al. ??TCR immunoglobulin constant region domain exchange in human ??TCRs improves TCR pairing without altering TCR gene-modified T cell function. Mol Med Rep. 2017;15:1555-1564 pubmed publisher
Shi J, Zhang D, Cui Z, Wang H. Preparation and application of a novel monoclonal antibody specific for human B7-H3. Mol Med Rep. 2016;14:943-8 pubmed publisher
Bredo G, Storie J, Shrestha Palikhe N, Davidson C, Adams A, Vliagoftis H, et al. Interleukin-25 initiates Th2 differentiation of human CD4(+) T cells and influences expression of its own receptor. Immun Inflamm Dis. 2015;3:455-68 pubmed publisher
Herrera R, Morris M, Rosbe K, Feng Z, Weinberg A, Tugizov S. Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells. Virology. 2016;487:172-87 pubmed publisher
Liu R, Wang Z, Gou L, Xu H. A cortical astrocyte subpopulation inhibits axon growth in vitro and in vivo. Mol Med Rep. 2015;12:2598-606 pubmed publisher
Moore C, Cui Q, Warsi N, Durafourt B, Zorko N, Owen D, et al. Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiation. J Immunol. 2015;194:761-72 pubmed publisher
Van Belle T, Vanherwegen A, Feyaerts D, De Clercq P, Verstuyf A, Korf H, et al. 1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patients. PLoS ONE. 2014;9:e109194 pubmed publisher
Zhu L, Huang Z, Stålesen R, Hansson G, Li N. Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation. J Thromb Haemost. 2014;12:1156-65 pubmed publisher
Foley M, Forcier T, McAndrew E, Gonzalez M, Chen H, Juelg B, et al. High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function. PLoS ONE. 2014;9:e87873 pubmed publisher
Dalmas E, Venteclef N, Caer C, Poitou C, Cremer I, Aron Wisnewsky J, et al. T cell-derived IL-22 amplifies IL-1?-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63:1966-77 pubmed publisher
Renand A, Milpied P, Rossignol J, Bruneau J, Lemonnier F, Dussiot M, et al. Neuropilin-1 expression characterizes T follicular helper (Tfh) cells activated during B cell differentiation in human secondary lymphoid organs. PLoS ONE. 2013;8:e85589 pubmed publisher
Gironi M, Saresella M, Rovaris M, Vaghi M, Nemni R, Clerici M, et al. A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis. Immun Ageing. 2013;10:1 pubmed publisher
Elmarghani A, Abuabaid H, Kjellen P. TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation. Mediators Inflamm. 2009;2009:416298 pubmed publisher
Wolk K, Witte E, Warszawska K, Schulze Tanzil G, Witte K, Philipp S, et al. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur J Immunol. 2009;39:3570-81 pubmed publisher
Hirosako S, Goto E, Fujii K, Tsumori K, Hirata N, Tsumura S, et al. Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells. Clin Exp Immunol. 2009;155:266-74 pubmed publisher
Lazer G, Pe er L, Schapira V, Richard S, Katzav S. The association of Sam68 with Vav1 contributes to tumorigenesis. Cell Signal. 2007;19:2479-86 pubmed
Celis E. Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction. Cancer. 2007;110:203-14 pubmed
Sakthivel P, Shively V, Kakoulidou M, Pearce W, Lefvert A. The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysm. J Intern Med. 2007;261:399-407 pubmed
Bayry J, Triebel F, Kaveri S, Tough D. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J Immunol. 2007;178:4184-93 pubmed
Srinivasan M, Eri R, Zunt S, Summerlin D, Brand D, Blum J. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent. Arthritis Rheum. 2007;56:498-508 pubmed
Piconi S, Trabattoni D, Saresella M, Iemoli E, Schenal M, Fusi A, et al. Effects of specific immunotherapy on the B7 family of costimulatory molecules in allergic inflammation. J Immunol. 2007;178:1931-7 pubmed
Mamoni R, Blotta M. Flow-cytometric analysis of cytokine production in human paracoccidioidomycosis. Cytokine. 2006;35:207-16 pubmed
Neuber K, Mähnss B, Hubner C, Gergely H, Weichenthal M. Autoantibodies against CD28 are associated with atopic diseases. Clin Exp Immunol. 2006;146:262-9 pubmed
Ogilvie R, Abelson M, Hau H, Vlasova I, Blackshear P, Bohjanen P. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J Immunol. 2005;174:953-61 pubmed
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-54 pubmed
Wang P, Zhang J, Bian H, Wu P, Kuvelkar R, Kung T, et al. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem J. 2004;380:425-33 pubmed
Janardhan A, Swigut T, Hill B, Myers M, Skowronski J. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol. 2004;2:E6 pubmed
Wolk K, Kunz S, Asadullah K, Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J Immunol. 2002;168:5397-402 pubmed
product information
brand :
R&D Systems
master code :
MAB342
SKU :
MAB342-100
product name :
Human CD28 Antibody
unit size :
100 ug (also 25 ug, 500 ug)
seo description :
The Human CD28 Antibody from R&D Systems is a mouse monoclonal antibody to CD28. This antibody reacts with human,mouse. The Human CD28 Antibody has been validated for the following applications: Bioassay,Binding Assay,ELISA Development,Polarization,Stimulation,T Cell Activation,Tissue Culture,Flow Cytometry,Western Blot,Neutralization,Functional Assay,Cell Culture,Immunocytochemistry,Agonist Activity.
target :
CD28
category :
Primary Antibodies
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.
clonality :
Monoclonal
clone :
37407
conjugate :
Unconjugated
dilution :
Western Blot 1 ug/mL, Agonist Activity 0.2-0.6 ug/mL, Immunocytochemistry 8-25 ug/mL
host :
Mouse
immunogen :
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human CD28, Asn19-Pro152, Accession # P10747
isotype :
IgG1
purity :
Protein A or G purified from ascites
species :
Human,Mouse
specificity :
Detects human CD28 in Western blots. In Western blots, this antibody does not cross-react with recombinant mouse (rm) CD28, rhCTLA4, or rmCTLA4.
gene symbol :
CD28
endotoxin note :
<0.10 EU per 1 ╡g of the antibody by the LAL method.
top caption :
Human CD28 Antibody Enhances IL-2 Secretion antibody in Jurkat Cells.
accessionNumbers :
P10747
applications :
Agonist Activity,Bioassay,Binding Assay,ELISA Development,Polarization,Stimulation,T Cell Activation,Tissue Culture,Flow Cytometry,Western Blot,Neutralization,Immunocytochemistry,Functional Assay,Cell Culture
USD :
489 USD
alt names :
CD28, CD28 antigen, CD28 antigen (Tp44), CD28 molecule, MGC138290, T-cell-specific surface glycoprotein CD28, Tp44
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.